Dana Investment Advisors Inc. cut its stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 7.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,409 shares of the biotechnology company’s stock after selling 1,315 shares during the period. […]
Dana Investment Advisors Inc. decreased its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 7.9% during the third quarter, HoldingsChannel.com reports. The firm owned 15,409 shares of the biotechnology company’s stock after selling 1,315 shares during the quarter. Dana Investment Advisors Inc.’s holdings in Rocket Pharmaceuticals were worth $316,000 at the end of […]
Despite all the uncertainty in Donald Trump s Georgia election-interference case, several legal experts said one thing has become clear: Fani Willis s case has been damaged. Willis, the Fulton. -March 01, 2024 at 06:12 am EST
- MarketScreener
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report)‘s stock had its “overweight” rating reiterated by investment analysts at Cantor Fitzgerald in a report released on Tuesday, Benzinga reports. They currently have a $65.00 price target on the biotechnology company’s stock. Cantor Fitzgerald’s price target would suggest a potential upside of 123.91% from the stock’s previous close. […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report)‘s stock had its “overweight” rating restated by investment analysts at Cantor Fitzgerald in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $65.00 target price on the biotechnology company’s stock. Cantor Fitzgerald’s price objective suggests a potential upside of 118.93% from the stock’s […]